SOCS3 and cholangiocarcinoma: However, we noticed that 17.5% of the patients in this study did not fit into the category where the relationship between A20 and SOCS3 was inverse (Fig 3), and this result indicates that there might be alternative oncogenic pathways in CCA development for these patients.